Tag:
Biotronik
Latest Headlines
Latest Headlines
UPDATED: Biotronik's drug-coated balloon wows with promising 6-month results
Biotronik says an ongoing clinical study has generated promising 6-month results using its Passeo-18 Lux drug-coated balloon to treat leg blood clots, compared to standard balloon angioplasty.
Biotronik wins FDA approval for next-gen ICD and CRT-D
The competition to gain market share with next-generation ICD and CRT-Ds just got tougher. German device giant Biotronik won FDA regulatory approval for its new Lumax 740 implantable cardioverter defibrillators and cardiac resynchronization therapy devices.
BIOTRONIK's Lumax 740 implanted in first patients
Berlin's BIOTRONIK reported the first implantations of the new Lumax 740 implantable cardiac defibrillators. The Lumax 740 series is the world's first and only ICD series eligible for use with
Biotronik: Enrollment complete in 4EVER study
Biotronik reported Tuesday that all 120 patients have been enrolled in the 4EVER clinical study evaluating the safety and efficacy of the Astron Pulsar and Pulsar-18 stents. The primary endpoint is
NYT report highlights Biotronik sales tactics
The New York Times' Barry Meier has a new report out about Biotronik's sales practices. In his latest story, Meier offers what he calls "a portrait of an implant industry" in which producers try to
Medtronic's decision to end GPO contracts could aid rivals
Medtronic's move to cancel with group purchasing organizations Novation and Premier might be backfiring. Although it anticipated that rivals, including St. Jude Medical, would follow its lead, they
GPO Novation signs Biotronik
Roughly two weeks after inking a 30-month agreement for cardiac rhythm management products with St. Jude Medical , group purchasing organization Novation has now added Biotronik as a partner. The two
Biotronik responds to NYT report
Biotronik is striking back after articles appearing in the New York Times questioned payments the company made to Nevada doctors. After these reports appeared, state officials began looking into
Nevada officials look into Biotronik payments to docs
Officials in Nevada are trying to determine if a German heart device company inappropriately paid doctors to use its products. The move comes after a piece appearing Sunday in the New York Times
